Adcirca and Glucophage drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adcirca (tadalafil) and Glucophage (metformin hydrochloride). Common drug interactions include fatigue among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Adcirca and Glucophage. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Adcirca?

Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.

What is Glucophage?

Glucophage has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 60,851 Glucophage users. Check the latest studies of Glucophage.



On Jul, 12, 2026

56 people who take Adcirca and Glucophage together, and have interactions are studied.

Adcirca and Glucophage drug interactions.

What are the common drug interactions of Adcirca and Glucophage, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Hypoxia (low oxygen in tissues)
  3. Influenza
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Blood glucose fluctuation
  6. Chills (felling of cold)
  7. Ear pain
  8. Epistaxis (bleed from the nose)
  9. Lacrimation increased
  10. Rhinorrhoea (watery mucus discharge from the nose)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cardiac failure
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Anaemia (lack of blood)
  5. Brain natriuretic peptide increased
  6. Decreased appetite
  7. Hypotension (abnormally low blood pressure)
  8. Muscle spasms (muscle contraction)
  9. Renal failure (kidney dysfunction)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Adcirca and Glucophage, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. Infusion site cellulitis
  3. Infusion site haemorrhage (bleeding from infusion site)
  4. Infusion site infection
  5. Infusion site pain
  6. Puncture site discharge

40-49:

  1. Death

50-59:

  1. Hepatomegaly (abnormal enlargement of the liver)
  2. Influenza
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Oedema peripheral (superficial swelling)
  5. Oropharyngeal pain
  6. Toothache (tooth pain)
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. Brain natriuretic peptide increased
  9. Cellulitis (infection under the skin)
  10. Dizziness

60+:

  1. Headache (pain in head)
  2. Dizziness
  3. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  4. Right ventricular failure (right half of the heart fails to work)
  5. Cardiac failure
  6. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Diarrhoea
  9. Oedema (fluid collection in tissue)
  10. Orthopnoea (shortness of breath (dyspnea) when lying down)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 38 people, 67.86%
  2. Type 2 Diabetes: 5 people, 8.93%
  3. Pain: 5 people, 8.93%
  4. Dyspnea (difficult or laboured breathing): 4 people, 7.14%
  5. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 3 people, 5.36%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Adcirca and Glucophage?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adcirca and Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adcirca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adcirca and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucophage and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tadalafil and metformin hydrochloride (the active ingredients of Adcirca and Glucophage, respectively), and Adcirca and Glucophage (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: